← Back to Search

Honey-Flavored Yogurt for Inflammation

N/A
Recruiting
Led By Carl L Keen, PhD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Postmenopausal female: 45-65 years
Women: lack of menses for at least two years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial will test the effects of honey-flavored yogurt on inflammation, oxidative stress, and microbial metabolites.

Who is the study for?
This trial is for postmenopausal women aged 45-65 with a BMI of 25.0 - 30.0 kg/m2 who are willing to follow the study protocols. It's not suitable for those with recent cancer, high blood pressure, heart disease, liver or kidney issues, certain dietary restrictions (vegans/vegetarians), or taking various supplements and medications.Check my eligibility
What is being tested?
The study aims to compare the effects of honey-flavored yogurt versus sugar-sweetened yogurt on inflammation and gut health over four weeks. It will measure changes in inflammatory markers, oxidative stress levels, metabolism, and gut microbiome in middle-aged women.See study design
What are the potential side effects?
Potential side effects may include digestive discomfort due to dairy or honey intake and possible allergic reactions if participants have unknown allergies to ingredients in the yogurts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman aged 45-65 and have gone through menopause.
Select...
I have not had a menstrual period for at least two years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Concentration of CD4+ T Helper (TH)17 cytokines
Secondary outcome measures
Concentration of Secondary bile acids
Concentration of Short chain fatty acids
Concentration of soluble NADPH oxidase (NOX2)
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Honey sweetened yogurtExperimental Treatment1 Intervention
1 tbsp. of honey in 0.6 cup (150g) of plain yogurt. The participants will be asked to consume 2 morning servings of the yogurt for a total of 2 tbsp. of the assigned honey per day.
Group II: Sugar sweetened yogurtPlacebo Group1 Intervention
Sugar will be added to 0.6 cup (150g) of plain yogurt in an isocaloric amount compared to the honey. The participants will be asked to consume 2 morning servings of the yogurt per day.

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
911 Previous Clinical Trials
4,709,563 Total Patients Enrolled
30 Trials studying Obesity
33,569 Patients Enrolled for Obesity
Carl L Keen, PhDPrincipal InvestigatorUniversity of California, Davis; Department of Nutrition
15 Previous Clinical Trials
419 Total Patients Enrolled
1 Trials studying Obesity
21 Patients Enrolled for Obesity

Media Library

Honey-flavored Yogurt Clinical Trial Eligibility Overview. Trial Name: NCT04248127 — N/A
Obesity Research Study Groups: Honey sweetened yogurt, Sugar sweetened yogurt

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the uppermost capacity of participants for this trial?

"Correct. According to the information available on clinicaltrials.gov, this clinical trial is presently recruiting patients; it was posted on November 1st 2021 and its most recent edit came on January 25th 2022. The study needs 20 participants from a single medical site."

Answered by AI

Are there vacancies in this clinical trial for eligible individuals?

"Affirmative. The information available on clinicaltrials.gov affirms that this trial, first posted in November 2021 and most recently updated in January 2022, is actively searching for 20 patients to participate from a single site."

Answered by AI

What are the eligibility criteria for this research project?

"This medical trial is currently accepting 20 patients aged between 45 and 65 who have overweight."

Answered by AI

Is admission to this trial exclusive to individuals aged 70 years and below?

"This medical trial has a narrow age criteria, with only those between 45-65 accepted. Conversely, there are 80 clinical trials available for people under 18 and 468 studies open to senior citizens aged 65 or above."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
University of California, Davis; Department of Nutrition
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
~4 spots leftby Dec 2024